Becker's Healthcare September 16, 2024
Alexandra Murphy

Sanofi received FDA approval for a new manufacturing line to expand production of Beyfortus, a preventive therapy for respiratory syncytial virus in infants.

Beyfortus is the first long-acting monoclonal antibody approved by the FDA to prevent RSV-related lower respiratory tract disease in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma / Biotech
A Sea-Change is Coming in How Laboratory-Developed Tests are Regulated – Is your Lab Ready?
The AI assurance labs are coming
The FDA Isn’t Blocking Medical Breakthroughs — Our Outdated Innovation Model Is
FDA Clears First 1-Year CGM for Diabetes
InnovationRx: FDA Commissioner Talks Healthcare AI

Share This Article